Company intelligence / Profile preview

Etta Biotech

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Etta Biotech develops and commercializes electroporator instruments and related systems used for gene delivery, genome editing, and cell transfection in research and bioprocess settings.[2][3] There is no evidence the company runs its own therapeutic clinical trials; rather, its products support research and development, including oncology and cell/gene therapy applications.[2][3]

Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Jianshun Biotech (strategic cooperation on electroporation applications and promotion)

Beyond the preview

Go deeper on Etta Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Etta Biotech.

Explore the full profile